MINAPHARM Pharmaceuticals reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was EGP 553.76 million compared to EGP 500.53 million a year ago. Net income was EGP 70.35 million compared to EGP 95.61 million a year ago. Basic earnings per share from continuing operations was EGP 5.19 compared to EGP 7.32 a year ago.
For the six months, sales was EGP 1,104.12 million compared to EGP 1,027.38 million a year ago. Net income was EGP 145.53 million compared to EGP 153.53 million a year ago. Basic earnings per share from continuing operations was EGP 11.46 compared to EGP 11.73 a year ago.